BRIEF published on 07/23/2025 at 12:55, 4 months 12 days ago Waldencast Acquires Novaestiq Corp. from Gore Range Capital Acquisition FDA Approval Injectable Gel Obagi Medical Waldencast
BRIEF published on 07/23/2025 at 12:55, 4 months 12 days ago Waldencast acquiert Novaestiq Corp. auprès de Gore Range Capital Acquisition Approbation De La FDA Obagi Medical Waldencast Gel Injectable
PRESS RELEASE published on 07/23/2025 at 12:50, 4 months 12 days ago Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast Waldencast to acquire Novaestiq Corp. under Obagi Medical, strengthening portfolio with injectable hyaluronic acid gels for US market. Saypha® products set to redefine skincare experience Obagi Medical Waldencast Novaestiq Corp. Saypha® Injectable Hyaluronic Acid Gels
Published on 12/05/2025 at 02:35, 4 hours 3 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 38 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 33 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 38 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 8 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 47 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 13 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 23 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 27 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 23 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 38 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 38 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 53 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 53 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
